RankingsPricing
  1. JP-listed companies
  2. COSMOS Pharmaceutical Corporation
  3. Financials
  4. Revenue growth (%)

COSMOS Pharmaceutical Corporation【JP:3349】

Market cap
¥570B
P/E ratio
18.2x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue growth (%) YoY (%)
May 31, 20254.8-71.01%
May 31, 202416.6+73.35%
May 31, 20239.6+139.85%
May 31, 20224-35.02%
May 31, 20216.1-48.79%
May 31, 202012+25.95%
May 31, 20199.5-13.38%
May 31, 201811-11.37%
May 31, 201712.4+30.53%
May 31, 20169.5-3.55%
May 31, 20159.9-23.70%
May 31, 201412.9-28.36%
May 31, 201318+2.15%
May 31, 201217.6

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)